Compliance Issues To Focus On Vetting Employees In China After GSK Sex Tape Revelations
This article was originally published in PharmAsia News
Executive Summary
Startling revelations that the trigger for the China compliance storm was a sex tape sent to GSK executives along with allegations leaders of its China unit were bribing physicians and hospitals to prescribe its drug has put the biomedical industry in the country on high alert. The result is an expected push to include material in training on how personal behavior is just as important, if not more, than professional, legal experts say.